Elizabeth Howard, Ph.D.

Elizabeth Howard, Ph.D.

Former Executive Vice President, General Counsel, Chief Compliance Officer and SecretaryatArbutus Biopharma· In proxies 2022–2023

Pay in FY2022Arbutus Biopharma stock -40.1% the same year

Elizabeth Howard, Ph.D. was paid $0 in FY2022 (Dec). Arbutus Biopharma stock fell 40.1% that year.

Pay$100 in the stock at the end of FY21 → $60
Pay is from the Summary Compensation Table of each Arbutus Biopharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Arbutus BiopharmaPublic company · 4 yr
    • Former Executive Vice President, General Counsel, Chief Compliance Officer and Secretary2022 – Present · 4 yrStock in role +12%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?